Personalized therapy in metastatic colorectal cancer: biomarker-driven use of biologics
{{output}}
Introduction: Metastatic colorectal cancer (mCRC) remains a leading cause of cancer mortality worldwide, with limited long-term survival despite therapeutic advances. The increasing understanding of its molecular heterogeneity ha... ...
